Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sartorius (0NIR) Share Price & Analysis

0NIR Stock Chart & Stats

€290.60-€7.90(-2.65%)
At close: 4:30 PM GMT
€225€250€275€3003 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 290.10 - EUR 297.80
52-Week Range
EUR 198.75 - EUR 299.05
Previous Close
EUR 298.50
Volume
152
Average Volume (3M)
36.21K
Market Cap
EUR 18.00B
Enterprise Value
EUR 22.80B
Total Cash (Recent Filing)
EUR 230.70M
Total Debt (Recent Filing)
EUR 3.91B
Price to Earnings (P/E)
72.5
Beta
1.46
Next Earnings
Feb 23, 2027 (Est.)
EPS Estimate
1.51
Next Dividend Ex-Date
N/A
Dividend Yield
0.26%

Bulls Say, Bears Say

Bulls Say

Recurring Bioprocess Revenue

The mix of replenishable single-use and filtration products can create repeat purchasing linked to customers’ production volumes. This recurring element gives Sartorius a more durable revenue base than a business dependent only on occasional equipment sales and supports customer retention over multiple production cycles.

Improving Profitability And Cash Flow

Recovered operating profitability and stronger free cash flow indicate that Sartorius is rebuilding earnings quality after the 2024 weakness. Positive and improving cash generation supports debt service, ongoing research and development, and investment in the company’s long-term bioprocess platform.

Biologics Industry Positioning

Sartorius is positioned in a specialized life-science market through tools used in biologic development and manufacturing. Its exposure to regulated pharmaceutical, biotech, and research workflows can support durable customer relationships because these processes require validated equipment, consumables, and services.

Bears Say

Modest Revenue Growth

Low-single-digit revenue growth shows that the recovery in demand has not yet translated into a strong expansion of the top line. Remaining below the 2022 peak suggests customer investment cycles and product mix have not fully normalized, limiting near-term operating leverage and growth visibility.

Elevated Leverage

Debt remains high relative to equity despite improving from 2023, leaving Sartorius with less financial flexibility if growth slows or margins compress. Elevated leverage can constrain capital allocation, increase the importance of consistent cash generation, and reduce room for sizable strategic investment.

Weak Cash Conversion

Although free cash flow is positive and improving, its level remains well below reported net income. This indicates that working-capital demands or reinvestment needs are absorbing a meaningful share of accounting earnings, reducing the cash available for debt reduction, investment, or shareholder returns.

Sartorius News

0NIR FAQ

What was Sartorius’s price range in the past 12 months?
Sartorius lowest share price was €198.75 and its highest was €299.05 in the past 12 months.
What is Sartorius’s market cap?
Sartorius’s market cap is €18.00B.
When is Sartorius’s upcoming earnings report date?
Sartorius’s next earnings report is estimated for Feb 23, 2027 (not yet confirmed), which is in 113 days.
How were Sartorius’s earnings last quarter?
Sartorius released its earnings results on Oct 22, 2026. The company reported €1.27 earnings per share for the quarter, beating the consensus estimate of €1.251 by €0.019.
Is Sartorius overvalued?
According to Wall Street analysts Sartorius’s price is currently Overvalued.
Does Sartorius pay dividends?
Sartorius does not currently pay dividends.
What is Sartorius’s EPS estimate?
Sartorius’s EPS estimate is 1.51.
How many shares outstanding does Sartorius have?
Sartorius has 37,440,000 shares outstanding.
What happened to Sartorius’s price movement after its last earnings report?
Sartorius reported an EPS of €1.27 in its last earnings report, beating expectations of €1.251. Following the earnings report the stock price went up 5.509%.
Which hedge fund is a major shareholder of Sartorius?
Currently, no hedge funds are holding shares in GB:0NIR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology